---
reference_id: "PMID:33811134"
title: Patients with KCNH1-related intellectual disability without distinctive features of Zimmermann-Laband/Temple-Baraitser syndrome.
authors:
- Aubert Mucca M
- Patat O
- Whalen S
- Arnaud L
- Barcia G
- Buratti J
- Cogné B
- Doummar D
- Karsenty C
- Kenis S
- Leguern E
- Lesca G
- Nava C
- Nizon M
- Piton A
- Valence S
- Villard L
- Weckhuysen S
- Keren B
- Mignot C
journal: J Med Genet
year: '2022'
doi: 10.1136/jmedgenet-2020-107511
content_type: abstract_only
---

# Patients with KCNH1-related intellectual disability without distinctive features of Zimmermann-Laband/Temple-Baraitser syndrome.
**Authors:** Aubert Mucca M, Patat O, Whalen S, Arnaud L, Barcia G, Buratti J, Cogné B, Doummar D, Karsenty C, Kenis S, Leguern E, Lesca G, Nava C, Nizon M, Piton A, Valence S, Villard L, Weckhuysen S, Keren B, Mignot C
**Journal:** J Med Genet (2022)
**DOI:** [10.1136/jmedgenet-2020-107511](https://doi.org/10.1136/jmedgenet-2020-107511)

## Content

1. J Med Genet. 2022 May;59(5):505-510. doi: 10.1136/jmedgenet-2020-107511. Epub 
2021 Apr 2.

Patients with KCNH1-related intellectual disability without distinctive features 
of Zimmermann-Laband/Temple-Baraitser syndrome.

Aubert Mucca M(1), Patat O(2), Whalen S(3), Arnaud L(4), Barcia G(5), Buratti 
J(4), Cogné B(6), Doummar D(7), Karsenty C(8), Kenis S(9), Leguern E(4), Lesca 
G(10)(11), Nava C(4), Nizon M(6), Piton A(12), Valence S(7), Villard L(13), 
Weckhuysen S(14)(15), Keren B(4), Mignot C(4)(16)(17).

Author information:
(1)Service de Génétique Médicale, CHU Toulouse Purpan, Toulouse, France.
(2)Service de Génétique Médicale, CHU Toulouse Purpan, Toulouse, France 
patat.o@chu-toulouse.fr.
(3)Unité Fonctionnelle de Génétique Clinique, Centre de Référence Anomalies du 
développement et syndromes malformatifs, APHP.Sorbonne Université, Hôpital 
Armand Trousseau, Paris, Île-de-France, France.
(4)APHP.Sorbonne Université, Département de Génétique, Groupe Hospitalier Pitié 
Salpêtrière et Hôpital Trousseau, Paris, Île-de-France, France.
(5)APHP, Service de Génétique Médicale, Hôpital Necker-Enfants Malades, Imagine 
Institute, Paris Descartes University, Paris, France.
(6)Service de Génétique Médicale, L'institut du thorax, INSERM, CNRS, UNIV 
Nantes, Centre Hospitalier Universitaire de Nantes, Nantes, France.
(7)Service de Neuropédiatrie - Unité de neuropédiatrie et pathologie du 
développement, CHU Paris Est - Hôpital d'Enfants Armand-Trousseau, Paris, 
France.
(8)Service de Neuropédiatrie, CHU Toulouse, Hôpital des Enfants, Toulouse, 
France.
(9)Child Neurology Department, University of Antwerp, University Hospital 
Antwerp, Edegem, Antwerp, Belgium.
(10)EuroEPINOMICS, EuroEPINOMICS, Strasbourg, France.
(11)Service de Génétique, LBMMS, Groupement Hospitalier Est, CHU de Lyon, Lyon, 
France.
(12)Laboratory of Genetic Diagnosis, Hôpitaux Universitaires de Strasbourg, 
Strasbourg, France.
(13)Laboratoire de génétique moléculaire, Département de Génétique Médicale, CHU 
de Marseille - Hôpital La Timone, Marseille, France.
(14)Applied&Translational Genomics group, VIB-Center for Molecular Neurology, 
University of Antwerp, Antwerp, Belgium.
(15)Neurology Department, University Hospital Antwerp, Antwerp, Belgium.
(16)INSERM, U1127, CNRS UMR 7225, Sorbonne Université, UPMC Univ Paris 06 UMR 
S1127, Institut du Cerveau et la Moelle épinière ICM, Paris, France.
(17)Centre de Référence Déficiences Intellectuelles de Causes Rares, GH Pitié 
Salpêtrière, Paris, France.

De novo missense variants in KCNH1 encoding Kv10.1 are responsible for two 
clinically recognisable phenotypes: Temple-Baraitser syndrome (TBS) and 
Zimmermann-Laband syndrome (ZLS). The clinical overlap between these two 
syndromes suggests that they belong to a spectrum of KCNH1-related 
encephalopathies. Affected patients have severe intellectual disability (ID) 
with or without epilepsy, hypertrichosis and distinctive features such as 
gingival hyperplasia and nail hypoplasia/aplasia (present in 20/23 reported 
cases).We report a series of seven patients with ID and de novo pathogenic KCNH1 
variants identified by whole-exome sequencing or an epilepsy gene panel in whom 
the diagnosis of TBS/ZLS had not been first considered. Four of these variants, 
p.(Thr294Met), p.(Ala492Asp), p.(Thr493Asn) and p.(Gly496Arg), were located in 
the transmembrane domains S3 and S6 of Kv10.1 and one, p.(Arg693Gln), in its 
C-terminal cyclic nucleotide-binding homology domain (CNBHD). Clinical 
reappraisal by the referring clinical geneticists confirmed the absence of the 
distinctive gingival and nail features of TBS/ZLS.Our study expands the 
phenotypical spectrum of KCNH1-related encephalopathies to individuals with an 
attenuated extraneurological phenotype preventing a clinical diagnosis of TBS or 
ZLS. This subtype may be related to recurrent substitutions of the Gly496, 
suggesting a genotype-phenotype correlation and, possibly, to variants in the 
CNBHD domain.

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and 
permissions. Published by BMJ.

DOI: 10.1136/jmedgenet-2020-107511
PMID: 33811134 [Indexed for MEDLINE]

Conflict of interest statement: Competing interests: None declared.